STAT

Opinion: Novel coronavirus 2019-nCoV exposes a flaw in the Nagoya Protocol

As the number of people infected with the novel coronavirus 2019-nCoV increases each day, scientists around the world are racing to find a treatment. Since the virus was first reported from Wuhan, China, at the end of December, and the declaration of a public health emergency of international concern on Jan. 30, commitments to fund research and development efforts are being made by governments, research institutes, partnerships and companies.

As the clock ticks, we should take a moment to realize we are witnessing something quite remarkable: The with which science about 2019-nCoV is being shared.

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Cigna Biosimilar Plans, A Vertex Deal In South Africa, And More
Cigna plans to make copies of AbbVie's Humira arthritis drug available with no out-of-pocket payment to eligible patients in the U.S.
STAT1 min read
USDA Faulted For Disclosing Scant Information About Outbreaks Of H5N1 Avian Flu In Cattle
With 28 herds in eight states infected with H5N1 bird flu, scientists are calling on the U.S. to release more data to help them assess the risk.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Biocon Eyeing Weight Loss Drugs, Sanofi Layoffs, And More
Biocon is pivoting to weight loss drugs as patents for the blockbuster medicines start to expire, unleashing a coming wave of generics.

Related Books & Audiobooks